27 May 2021
Watch this presentation by Dr. Ofer Sharon, CEO, OncoHost, titled: Proteomic analysis to predict response to immunotherapy. This talk was presented at the SelectScience® Virtual Cancer and Immunology Research Summit 2021.
OncoHost
Dr. Ofer Sharon received his M.D. from Tel Aviv University in 2000. With almost two decades of experience in the oncology drug development industry, Sharon is the CEO of OncoHost, a therapeutics company that develops personalized strategies to help maximize the success of cancer therapies by utilizing proprietary proteomic analysis.